BRIDGEBIO PHARMA INC

CUSIP: 10806XAD4 Class: Convertible Debt

LAZARD ASSET MANAGEMENT LLC's Holding History (CIK: 0001207017)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 5,519,000 Value ($000) $62 Avg Close — Range —
Q3 2025
Shares 12,853,000 Value ($000) $127 Avg Close — Range —
Q2 2025
Shares 12,019,000 Value ($000) $11 Avg Close — Range —
Q1 2025
Shares 5,519,000 Value ($000) $5 Avg Close — Range —
Q4 2024
Shares 5,519,000 Value ($000) $5 Avg Close — Range —
Q3 2024
Shares 5,519,000 Value ($000) $5 Avg Close — Range —